{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:09:46Z","timestamp":1785658186203,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-024-02489-4","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T14:02:23Z","timestamp":1730469743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: risk of heart failure"],"prefix":"10.1186","volume":"23","author":[{"given":"Rosa","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyuri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Bin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Man","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Yeon","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"2489_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK, et al. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10:107\u201311.","journal-title":"J Epidemiol Glob Health"},{"key":"2489_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157: 107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"2489_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576:51\u201360.","journal-title":"Nature"},{"key":"2489_CR4","doi-asserted-by":"publisher","first-page":"300060523116454","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, et al. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51:3000605231164548.","journal-title":"J Int Med Res"},{"key":"2489_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17:83.","journal-title":"Cardiovasc Diabetol"},{"key":"2489_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 2019;71:793\u2013801.","journal-title":"J Hepatol"},{"key":"2489_CR7","doi-asserted-by":"crossref","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789\u20131858.","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"2489_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","volume":"38","author":"M Urbich","year":"2020","unstructured":"Urbich M, Globe G, Pantiri K, et al. A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014\u20132020). Pharmacoeconomics. 2020;38:1219\u201336.","journal-title":"Pharmacoeconomics"},{"key":"2489_CR9","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2023.05","volume":"9","author":"B Shahim","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, et al. Global Public Health Burden of Heart Failure: An Updated Review. Card Fail Rev. 2023;9: e11.","journal-title":"Card Fail Rev"},{"key":"2489_CR10","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"2489_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108157","volume":"163","author":"MK Kim","year":"2020","unstructured":"Kim MK, Han K, Cho JH, et al. A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea. Diabetes Res Clin Pract. 2020;163: 108157.","journal-title":"Diabetes Res Clin Pract"},{"key":"2489_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.12997\/jla.2018.7.2.110","volume":"7","author":"BK Koo","year":"2018","unstructured":"Koo BK, Oh S, Kim YJ, et al. Prediction of Coronary Heart Disease Risk in Korean Patients with Diabetes Mellitus. J Lipid Atheroscler. 2018;7:110\u201321.","journal-title":"J Lipid Atheroscler"},{"key":"2489_CR13","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong S, Kim YY, Khang YH, et al. Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46:799\u2013800.","journal-title":"Int J Epidemiol"},{"key":"2489_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"key":"2489_CR15","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/diagnostics11122233","volume":"11","author":"EJ Cho","year":"2021","unstructured":"Cho EJ, Jung GC, Kwak MS, et al. Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population. Diagnostics (Basel). 2021;11:2233.","journal-title":"Diagnostics (Basel)"},{"key":"2489_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2337\/dc17-1590","volume":"41","author":"SH Wild","year":"2018","unstructured":"Wild SH, Walker JJ, Morling JR, et al. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. Diabetes Care. 2018;41:341\u20137.","journal-title":"Diabetes Care"},{"key":"2489_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/jgh.14856","volume":"35","author":"DH Sinn","year":"2020","unstructured":"Sinn DH, Kang D, Chang Y, et al. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study. J Gastroenterol Hepatol. 2020;35:833\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"2489_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12933-022-01483-y","volume":"21","author":"J Park","year":"2022","unstructured":"Park J, Kim G, Kim BS, et al. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2022;21:53.","journal-title":"Cardiovasc Diabetol"},{"key":"2489_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.638615","volume":"12","author":"CH Lee","year":"2021","unstructured":"Lee CH, Han KD, Kim DH, et al. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study. Front Endocrinol (Lausanne). 2021;12: 638615.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2489_CR20","doi-asserted-by":"crossref","unstructured":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J 2023;44:2544\u20132556.","DOI":"10.1093\/eurheartj\/ehad260"},{"key":"2489_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102292","volume":"65","author":"JH Moon","year":"2023","unstructured":"Moon JH, Jeong S, Jang H, et al. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023;65: 102292.","journal-title":"EClinicalMedicine"},{"key":"2489_CR22","doi-asserted-by":"crossref","unstructured":"Muthiah M, Ng CH, Chan KE, et al. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis. Ann Hepatol 2023;28:100762.","DOI":"10.1016\/j.aohep.2022.100762"},{"key":"2489_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13098-023-01102-0","volume":"15","author":"Z Wei","year":"2023","unstructured":"Wei Z, Huang Z, Song Z, et al. Metabolic Dysfunction-associated fatty liver disease and incident heart failure risk: the Kailuan cohort study. Diabetol Metab Syndr. 2023;15:137.","journal-title":"Diabetol Metab Syndr"},{"issue":"1213\u20131230","key":"2489_CR24","volume":"135","author":"C Krittanawong","year":"2022","unstructured":"Krittanawong C, Isath A, Rosenson RS, et al. Alcohol Consumption and Cardiovascular Health. Am J Med. 2022;135(1213\u20131230): e3.","journal-title":"Am J Med"},{"key":"2489_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-021-02040-2","volume":"19","author":"C Ding","year":"2021","unstructured":"Ding C, O\u2019Neill D, Bell S, et al. Association of alcohol consumption with morbidity and mortality in patients with cardiovascular disease: original data and meta-analysis of 48,423 men and women. BMC Med. 2021;19:167.","journal-title":"BMC Med"},{"key":"2489_CR26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.clnu.2017.05.007","volume":"37","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Wallin A, Wolk A. Alcohol consumption and risk of heart failure: Meta-analysis of 13 prospective studies. Clin Nutr. 2018;37:1247\u201351.","journal-title":"Clin Nutr"},{"key":"2489_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.numecd.2023.03.003","volume":"33","author":"R Ren","year":"2023","unstructured":"Ren R, Zheng Y. Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population. Nutr Metab Cardiovasc Dis. 2023;33:1349\u201357.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2489_CR28","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3390\/diagnostics13213316","volume":"13","author":"T Biciusca","year":"2023","unstructured":"Biciusca T, Stan SI, Balteanu MA, et al. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics (Basel). 2023;13:3316.","journal-title":"Diagnostics (Basel)"},{"key":"2489_CR29","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1097\/CM9.0000000000000503","volume":"132","author":"LD Chen","year":"2019","unstructured":"Chen LD, Huang JF, Chen QS, et al. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome. Chin Med J (Engl). 2019;132:2670\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"2489_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100753","volume":"5","author":"J Mertens","year":"2023","unstructured":"Mertens J, Weyler J, Dirinck E, et al. Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes. JHEP Rep. 2023;5: 100753.","journal-title":"JHEP Rep"},{"key":"2489_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12876-023-02717-3","volume":"23","author":"HN Kim","year":"2023","unstructured":"Kim HN, Jeon HJ, Choi HG, et al. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease. BMC Gastroenterol. 2023;23:77.","journal-title":"BMC Gastroenterol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02489-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T14:02:29Z","timestamp":1730469749000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02489-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02489-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4779085\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Samsung Medical Center approved this study (IRB 2024-03-104). Written informed consent was waived because all data was de-identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was waived because all data was de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"391"}}